Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexamethasone Implant + Ranibizumab in Wet AMD
NCT00775411Phase 2Completed
- Sponsor
- Allergan
- Start
- Nov 2008
- Primary completion
- Nov 2009
- Modality
- Orthosteric Ligands
- Countries
- 3
01
Overview
A Phase 2 trial of dexamethasone in exudative macular degeneration, sponsored by Allergan. Started Nov 2008; status: completed.
02
Drugs
dexamethasone
03
Conditions
exudative macular degeneration
Beyond the preview
Go deeper on NCT00775411.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00775411.